Major physical and psychological harms of methamphetamine use

References

• McKetin R, McLaren J, Kelly E. The Sydney methamphetamine market: patterns of supply, use, personal harms and social consequences. National Drug Law Enforcement Research Fund Monograph no. 13. Australasian Centre for Policing Studies, Adelaide 2005
   Google Scholar
• McKetin R, Kelly E, McLaren J. The characteristics of treatment provided for amphetamine use in New South Wales, Australia. Drug Alcohol Rev 2005; 24: 433–436
   PubMed Web of Science ®Google Scholar
• Darke S, Hall W. Levels and correlates of polydrug use among heroin users and regular amphetamine users. Drug Alcohol Depend 1995; 39: 231–235
   PubMed Web of Science ®Google Scholar
• Williamson A, Darke S, Ross J, Teesson M. The effects of persistence of cocaine use on 12 month outcomes for the treatment of heroin dependence. Drug Alcohol Depend 2006; 81: 293–300
   PubMed Web of Science ®Google Scholar
• Albertson T E, Derlet R W, Van Hoozen B E. Methamphetamine and the expanding complications of amphetamines. West J Med 1999; 170: 214–219
   PubMedGoogle Scholar
• Mendelson J, Jones R T, Upton R, Jacob P. Methamphetamine and ethanol interactions in humans. Clin Pharmacol Ther 1995; 57: 559–568
   PubMed Web of Science ®Google Scholar
• Brookoff D, Rotondo M F, Shaw L M, Campbell E A, Fields L. Cocaethylene levels in patients who test positive for cocaine. Ann Emerg Med 1996; 27: 316–320
   PubMed Web of Science ®Google Scholar
• Harris D S, Everhart E T, Mendelson J, Jones R T. The pharmacology of cocaethylene in humans following cocaine and ethanol administration. Drug Alcohol Depend 2003; 72: 169–182
   PubMed Web of Science ®Google Scholar
• Karch S B. Karch's pathology of drug abuse, 3rd edn. CRC Press, Boca Raton 2002
   Google Scholar
• Darke S, Degenhardt L, Mattick R. Mortality amongst illicit drug users. Epidemiology, causes and intervention. Cambridge University Press, Cambridge 2007
   Google Scholar
• Welder A A. A primary culture system of postnatal rat heart cells for the study of cocaine and methamphetamine toxicity. Toxicol Lett 1992; 60: 183–196
   PubMed Web of Science ®Google Scholar
• Kaye S, McKetin R, Duflou J, Darke S. Methamphetamine and cardiovascular pathology: a review of the evidence. Addiction 2007; 102: 1204–1211
   PubMed Web of Science ®Google Scholar
• Coffin P O, Galea S, Ahern J, Leon A C, Vlahov D, Tardiff K. Opiate, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990 – 1998. Addiction 2003; 98: 739–747
   PubMed Web of Science ®Google Scholar
• Darke S, Kaye S, Duflou J. Cocaine-related fatalities in New South Wales, Australia 1993 – 2002. Drug Alcohol Depend 2005; 77: 107–114
   PubMed Web of Science ®Google Scholar
• Karch S B, Stephens B G, Ho C H. Methamphetamine-related deaths in San Francisco: demographic, pathologic, and toxicological profiles. J Forensic Sci 1999; 44: 359–368
   PubMed Web of Science ®Google Scholar
• Logan B, Fligner C L, Haddix T. Cause and manner of death in fatalities involving methamphetamine. J Forensic Sci 1998; 43: 28–34
   PubMed Web of Science ®Google Scholar
• Hardman J G, Limbird L E, Molinoff P B, Ruddon R W, Gilman A G. The pharmacological basis of therapeutics, 9th edn. McGraw-Hill, New York 1996
   Google Scholar
• Brands B, Sproule B, Marshman J. Drugs and drug abuse, 3rd edn. Addiction Research Foundation, Ontario 1998
   Google Scholar
• Petitti D B, Sidney S, Quesenberry C, Bernstein A. Stroke and cocaine or amphetamine use. Epidemiology 1998; 9: 596–600
   PubMed Web of Science ®Google Scholar
• Richards J R, Bretz S W, Johnson E B, Turnipseed S D, Brofeldt B T, Derlet R W. Methamphetamine abuse and emergency department utilization. West J Med 1999; 170: 198–202
   PubMedGoogle Scholar
• Karch S B, Stephens M D, Ho C H. Relating cocaine blood concentrations to toxicity: an autopsy study of 99 cases. J Forensic Sci 1998; 43: 41–45
   PubMed Web of Science ®Google Scholar
• Lange R A, Hillis L D. Medical progress: cardiovascular complications of cocaine use. New Engl J Med 2001; 345: 351–358
   PubMed Web of Science ®Google Scholar
• Zhu B L, Oritani S, Shimotouge K, et al. Methamphetamine-related fatalities in forensic autopsy during 5 years in the southern half of Osaka city and surrounding areas. Forensic Sci Int 2000; 113: 443–447
   PubMed Web of Science ®Google Scholar
• Degenhardt L, Roxburgh A. 2005 cocaine and methamphetamine related drug-induced deaths in Australia. National Drug and Alcohol Research Centre, Sydney 2007
   Google Scholar
• Degenhardt L, Roxburgh A. Accidental drug-induced deaths due to opioids in Australia, 2005. National Drug and Alcohol Research Centre, Sydney 2007
   Google Scholar
• Darke S, Mattick R, Degenhardt L. The ratio of non-fatal to fatal overdose. Addiction 2003; 98: 1169–1170
   PubMed Web of Science ®Google Scholar
• Kaye S, Darke S. Non-fatal cocaine overdose among injecting and non-injecting cocaine users in Sydney, Australia. Addiction 2004; 99: 1315–1322
   PubMed Web of Science ®Google Scholar
• Huang C N, Wu D J, Chen K S. Acute myocardial infarction caused by transnasal inhalation of amphetamine. Jpn Heart J 1993; 34: 815–818
   PubMedGoogle Scholar
• Waksman J, Taylor R N, Bodor G S, Daly F FS, Jolliff H A, Dart R C. Acute myocardial infarction associated with methamphetamine use. Mayo Clin Proc 2001; 76: 323–326
   PubMed Web of Science ®Google Scholar
• Yeo K, Wijetunga M, Ito H, et al. The association of methamphetamine use and cardiomyopathy in young patients. Am J Med 2007; 120: 165–171
   PubMed Web of Science ®Google Scholar
• Varner K J, Ogden B A, Delcarpio J, Meleg-Smith S. Cardiovascular responses elicited by the ‘binge’ administration of methamphetamine. J Pharmacol Exp Ther 2002; 301: 152–159
   PubMed Web of Science ®Google Scholar
• Wijetunga M, Seto T, Lindsay J, Schatz I. Crystal methamphetamine-associated cardiomyopathy: tip of the iceberg?. J Toxicol Clin Toxicol 2003; 41: 981–986
   PubMed Web of Science ®Google Scholar
• Julien R M. A primer of drug action. Henry Holt and Company, New York 2001
   Google Scholar
• Sztajnkrycer M D, Hariharan S, Bond G R. Cardiac irritability and myocardial infarction in a 13-year-old girl following recreational amphetamine overdose. Ped Emerg Care 2002; 18: E11–15
   Google Scholar
• Swalwell C I, Davis G G. Methamphetamine as a risk factor for acute aortic dissection. J Forensic Sci 1999; 44: 23–26
   PubMed Web of Science ®Google Scholar
• Lan K C, Lin Y F, Yu F C, Lin C S, Chu P. Clinical manifestations and prognostic features of acute methamphetamine intoxication. J Formosa Med Assoc 1998; 97: 528–533
   PubMed Web of Science ®Google Scholar
• Turnipseed S D, Richards J R, Kirk J D, Diercks D B, Amsterdam E A. Frequency of acute coronary syndrome in patients presenting to the Emergency Department with chest pain after methamphetamine use. J Emerg Med 2003; 24: 369–373
   PubMed Web of Science ®Google Scholar
• Westover A N, McBride S, Haley R W. Stroke in young adults who abuse amphetamines or cocaine. Arch Gen Psychiatry 2007; 64: 495–502
   PubMed Web of Science ®Google Scholar
• Derlet R W, Horowitz B Z. Cardiotoxic drugs. Emerg Med Clin North Am 1995; 13: 771–791
   PubMedGoogle Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn, text revision. American Psychiatric Association, Washington, DC 2000
   Google Scholar
• Topp L, Mattick R. Validation of the amphetamine dependence syndrome and the SamDQ. Addiction 1997; 92: 839–845
   PubMed Web of Science ®Google Scholar
• McGregor C, Srisurapanont M, Jittiwutikarn J, Laobhripatr S, Wongtan T, White J M. The nature, time course and severity of methamphetamine withdrawal. Addiction 2005; 100: 320–329
   Web of Science ®Google Scholar
• McKetin R, Kelly E, McLaren J. The relationship between crystalline methamphetamine use and dependence. Drug Alcohol Depend 2006; 58: 198–204
   Google Scholar
• Kaye S, Darke S. A comparison of the harms associated with the injection of heroin and amphetamines. Drug Alcohol Depend 2000; 58: 189–195
   PubMed Web of Science ®Google Scholar
• Rawson R A, Washton A, Domier C, Reiber C. Drugs and sexual effects: role of drug type and gender. J Subst Abuse Treat 2002; 22: 103–108
   PubMed Web of Science ®Google Scholar
• Kall K, Olin R. Constant annual incidence of HIV infection among intravenous drug addicts. Lakartidningen 1992; 89: 2837–2840
   PubMedGoogle Scholar
• Farabee D, Prendergast M, Cartier J. Methamphetamine use and HIV risk among substance-abusing offenders in California. J Psychoact Drugs 2002; 34: 295–300
   PubMed Web of Science ®Google Scholar
• Lorvick J, Martinez A, Gee L, Kral A H. Sexual and injection risk among women who inject methamphetamine in San Francisco. J Urban Health 2006; 83: 497–505
   PubMed Web of Science ®Google Scholar
• Molitor F, Truax S R, Ruiz J D, Sun R K. Association of methamphetamine use during sex with risky sexual behaviors and HIV infection among non-injection drug users. West J Med 1998; 168: 93–97
   PubMedGoogle Scholar
• Yen C F. Relationship between methamphetamine use and risky sexual behavior in adolescents. Kaohsiung J Med Sci 2004; 20: 160–165
   PubMedGoogle Scholar
• Semple S J, Grant I, Patterson T L. Utilization of drug treatment programs by methamphetamine users: the role of social stigma. Am J Addict 2005; 14: 367–380
   PubMed Web of Science ®Google Scholar
• Zule W A, Desmond D P. An ethnographic comparison of HIV risk behaviors among heroin and methamphetamine injectors. Am J Drug Alcohol Abuse 1999; 25: 1–23
   PubMed Web of Science ®Google Scholar
• Koblin B A, Husnik M J, Colfax G, et al. Risk factors for HIV infection among men who have sex with men. AIDS 2006; 20: 731–739
   PubMed Web of Science ®Google Scholar
• Morin S F, Steward W T, Charlebois E D, et al. Predicting HIV transmission risk among HIV-infected men who have sex with men: findings from the healthy living project. J AIDS 2005; 40: 226–235
   PubMed Web of Science ®Google Scholar
• Buchacz K, McFarland W, Kellogg T A, et al. Amphetamine use is associated with increased HIV incidence among men who have sex with men in San Francisco. AIDS 2005; 19: 1423–1424
   PubMed Web of Science ®Google Scholar
• Burcham J L, Tindall B, Marmor M, Cooper D A, Berry G, Penny R. Incidence and risk factors for human immunodeficiency virus seroconversion in a cohort of Sydney homosexual men. Med J Aust 1989; 150: 639–643
   PubMed Web of Science ®Google Scholar
• Zweben J E, Cohen J B, Christian D, et al. Psychiatric symptoms in methamphetamine users. Am J Addict 2004; 13: 81–90
   Web of Science ®Google Scholar
• Curran C, Byrappa N, McBride A. Stimulant psychosis: systematic review. Br J Psychiatry 2004; 185: 196–204
   PubMed Web of Science ®Google Scholar
• Dammau A, Bergman B, Brismar B. Psychotic disorders among in-patients with abuse of cannabis, amphetamines and opiates. Do dopaminergic stimulants facilitate psychiatric illness?. Euro Psychiatry 1999; 14: 366–371
   PubMed Web of Science ®Google Scholar
• Farrell M, Boys A, Bebbingtin P, et al. Psychosis and drug dependence: results from a national survey of prisoners. Br J Psychiatry 2002; 181: 393–398
   PubMed Web of Science ®Google Scholar
• Graf K, Baer P E, Comstock B S. MMPI changes in briefly hospitalised non-narcotic drug users. Clinical observations. Arch Gen Psychiatry 1977; 43: 107–113
   Google Scholar
• J Caldwell. Amphetamine and related stimulants: chemical, biological, clinical and sociological aspects. Florida, CRC Press. 1980
   Google Scholar
• Harris D, Batki S L. Stimulant psychosis: symptom profile and acute clinical course. Am J Addict 2000; 9: 28–37
   PubMed Web of Science ®Google Scholar
• Iwanami A, Sugiyama A, Kuroki N, et al. Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan: a preliminary report. Acta Psychiatr Scand 1994; 89: 428–432
   PubMed Web of Science ®Google Scholar
• Sato M, Numachi Y, Hamamura T. Relapse of paranoid psychotic state in methamphetamine model of schizophrenia. Schizophr Bull 1992; 18: 115–122
   PubMed Web of Science ®Google Scholar
• Chen C K, Lin S K, Sham P C, et al. Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychol Med 2003; 33: 1407–1414
   PubMed Web of Science ®Google Scholar
• Chen C K, Lin S K, Sham P C, Ball D, Loh el-W, Murray R M. Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis. Am J Med Genet 2005; 136: 87–91
   PubMedGoogle Scholar
• Regier D A, Farmer M E, Rae D S, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA). JAMA 1990; 264: 2511–2518
   PubMed Web of Science ®Google Scholar
• McKetin R, McLaren J, Kelly E, Lubman D, Hides L. The prevalence of psychotic symptoms among methamphetamine users. Addiction 2006; 101: 1473–1478
   PubMed Web of Science ®Google Scholar
• Hall W, Hando J, Darke S, Ross J. Psychological morbidity and route of administration among amphetamine users in Sydney, Australia. Addiction 1996; 91: 81–87
   PubMed Web of Science ®Google Scholar
• Matsumoto T, Kanai T, Takeuchi N. Clinical features of adolescent methamphetamine abusers: current pattern of methamphetamine use. Jpn J Child Adolesc Psychiatry 2000; 41: 19–31
   Google Scholar
• Sommers I, Baskin D, Baskin-Sommers A. Methamphetamine use among young adults: health and social consequences. Addict Behav 2006; 31: 1469–1476
   PubMed Web of Science ®Google Scholar
• Thirthali J, Benegal V. Psychosis among substance users. Curr Opin Psychiatry 2006; 19: 239–245
   PubMed Web of Science ®Google Scholar
• Bartlett E, Hallin A, Chapman B, Angrist B. Selective sensitization to the psychosis inducing effects of cocaine: a possible marker for addiction relapse vulnerability?. Neuropsychopharmacology 1997; 16: 77–82
   PubMed Web of Science ®Google Scholar
• Brady K T, Lydiard R B, Malcolm R, Ballenger J C. Cocaine-induced psychosis. J Clin Psychiatry 1991; 52: 509–512
   PubMed Web of Science ®Google Scholar
• Copeland A L, Sorenson J L. Differences between methamphetamine users and cocaine users in treatment. Drug Alcohol Depend 2001; 62: 91–95
   PubMed Web of Science ®Google Scholar
• Hando J, Flaherty B, Rutter S. An Australian profile on the use of cocaine. Addiction 1997; 92: 173–182
   PubMed Web of Science ®Google Scholar
• Kaye S, Darke S. Injecting and non-injecting cocaine use in Australia: physical and psychological morbidity. Drug Alcohol Rev 2004; 23: 391–398
   PubMed Web of Science ®Google Scholar
• Pirkis J, Burgess P, Dunt D. Suicidal ideation and suicide attempts among Australian adults. Crisis 2000; 21: 16–25
   PubMedGoogle Scholar
• Lexau B J, Nelson D, Hatsukami D K. Comparing IV and non-IV cocaine users: characteristics of a sample of cocaine users seeking to participate in research. Am J Addict 1998; 7: 262–271
   PubMed Web of Science ®Google Scholar
• McKetin R, McLaren J, Riddell S, Robins L. The relationship between methamphetamine use and violent behaviour. NSW Bureau of Crime Statistics and Research Crime and Justice Bulletin no. 97, August 2006. NSW Bureau of Crime Statistics and Research, Sydney 2006
   Google Scholar
• Sokolov B P, Schlinder C W, Cadet J L. Chronic methamphetamine increases fighting in mice. Pharmacol Biochem Behav 2004; 77: 319–326
   PubMed Web of Science ®Google Scholar
• Sokolov B P, Cadet J L. Methamphetamine causes alteration in the MAP kinase-related pathways in the brains of mice that display increased aggression. Neuropsychopharmacology 2006; 31: 956–966
   PubMed Web of Science ®Google Scholar
• McEllistren J E. Affective and predatory violence: a bimodal classification system of aggression and violence. Aggress Violent Behav 2004; 10: 1–30
   Web of Science ®Google Scholar
• Cadet J L, Jayanthi S, Deng X. Methamphetamine-induced neuronal apoptosis involves the activation of multiple death pathways. Neurotoxicol Res 2005; 8: 199–206
   PubMed Web of Science ®Google Scholar
• Kita T, Wagner G C, Nakashima T. Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption. J Pharmacol Sci 2003; 92: 178–195
   PubMed Web of Science ®Google Scholar
• Nordahl T E, Salo R, Possin K, et al. Low N-acetyl-aspartate and high choline in the anterior cingulum of recently abstinent methamphetamine-dependent subjects: a preliminary proton MRS study. Magnetic resonance spectroscopy. Psychiatry Res 2002; 116: 43–52
   PubMed Web of Science ®Google Scholar
• Seiden L S, Commins D L, Vosmer G, Axt K, Marek G. Neurotoxicity in dopamine and 5-hydroxytryptamine terminal fields: a regional analysis in nigrostriatal and mesolimbic projections. Ann NY Acad Sci 1988; 537: 161–172
   PubMed Web of Science ®Google Scholar
• Clemens K J, McGregor I S, Hunt G E, Cornish J L. MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research. Drug Alcohol Rev 2007; 26: 9–15
   PubMed Web of Science ®Google Scholar
• Itzhak Y, Achat-Mendes C. Methamphetamine and MDMA (ecstasy) neurotoxicity: ‘of mice and men’. IUBMB Life 2004; 56: 249–255
   PubMed Web of Science ®Google Scholar
• Riddle E L, Fleckenstein A E, Hanson G R. Mechanisms of methamphetamine-induced dopaminergic neurotoxicity. AAPS J 2006; 8: E413–18
   Web of Science ®Google Scholar
• Imam S Z, el-Yazal J, Newport G D, et al. Methamphetamine-induced dopaminergic neurotoxicity: role of peroxynitrite and neuroprotective role of antioxidants and peroxynitrite decomposition catalysts. Ann NY Acad Sci 2001; 939: 366–380
   PubMed Web of Science ®Google Scholar
• Dluzen D E, McDermott J L. Developmental and genetic influences upon gender differences in methamphetamine-induced nigrostriatal dopaminergic neurotoxicity. Ann NY Acad Sci 2004; 1025: 205–220
   PubMed Web of Science ®Google Scholar
• Volkow N D, Chang L, Wang G J, et al. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 2001; 158: 2015–2021
   PubMed Web of Science ®Google Scholar
• Volkow N D, Chang L, Wang G J, et al. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci 2001; 21: 9414–9418
   PubMed Web of Science ®Google Scholar
• London E D, Simon S L, Berman S M, et al. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch Gen Psychiatry 2004; 61: 73–84
   PubMed Web of Science ®Google Scholar
• Sekine Y, Minabe Y, Ouchi Y, et al. Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms. Am J Psychiatry 2003; 160: 1699–1701
   PubMed Web of Science ®Google Scholar
• Sekine Y, Ouchi Y, Takei N, et al. Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Arch Gen Psychiatry 2006; 63: 90–100
   PubMed Web of Science ®Google Scholar
• Yui K, Ikemoto S, Ishiguro T, Goto K. Studies of amphetamine or methamphetamine psychosis in Japan: relation of methamphetamine psychosis to schizophrenia. Ann NY Acad Sci 2000; 14: 1–12
   Google Scholar
• Levine A J, Hardy D J, Miller E, Castellon S A, Longshore D, Hinkin C H. The effect of recent stimulant use on sustained attention in HIV-infected adults. J Clin Exp Neuropsychol 2006; 28: 29–42
   PubMed Web of Science ®Google Scholar
• Hoffman W F, Moore M, Templin R, McFarland B, Hitzemann R J, Mitchell S H. Neuropsychological function and delay discounting in methamphetamine-dependent individuals. Psychopharmacology 2006; 188: 162–170
   PubMed Web of Science ®Google Scholar
• Woods S P, Rippeth J D, Conover E, et al. HIV Neurobehavioral Research Center Group. Deficient strategic control of verbal encoding and retrieval in individuals with methamphetamine dependence. Neuropsychology 2005; 19: 35–43
   PubMed Web of Science ®Google Scholar
• Chang L, Smith L M, LoPresti C, et al. Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure. Psychiatry Res 2004; 132: 95–106
   PubMed Web of Science ®Google Scholar
• Chang L, Cloak C, Patterson K, Grob C, Miller E, Ernst T. Enlarged striatum in abstinent methamphetamine abusers: a possible compensatory response. Biol Psychiatry 2005; 57: 967–974
   PubMed Web of Science ®Google Scholar
• Sadek J R, Vigil O, Grant I, Heaton R K. The HNRC Group. The impact of neuropsychological functioning and depressed mood on functional complaints in HIV-1 infection and methamphetamine dependence. J Clin Exp Neuropsychol 2007; 29: 266–276
   PubMed Web of Science ®Google Scholar
• Jaffe C, Bush K R, Straits-Troster K, et al. A comparison of methamphetamine-dependent inpatients childhood attention deficit hyperactivity disorder symptomatology. J Addict Dis 2005; 24: 133–152
   PubMed Web of Science ®Google Scholar
• Rippeth J D, Heaton R K, Carey C L, , for the HNRC Group, et al. Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc 2004; 10: 1–14
   PubMed Web of Science ®Google Scholar
• Cherner M, Letendre S, Heaton R K, et al. HIV Neurobehavioral Research Center Group. HIV Neurobehavioral Research Center Group. Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine [see comment]. Neurology 2005; 64: 1343–1347
   PubMed Web of Science ®Google Scholar
• Gonzalez R, Rippeth J D, Carey C L, et al. Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure. Drug Alcohol Depend 2004; 76: 181–190
   PubMed Web of Science ®Google Scholar
• Chang L, Ernst T, Speck O, et al. Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users. Psychiatry Res 2002; 114: 65–79
   PubMed Web of Science ®Google Scholar
• Volkow N D, Chang L, Wang G J, et al. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 2001; 158: 377–382
   PubMed Web of Science ®Google Scholar
• Caligiuri M P, Buitenhuys C. Do preclinical findings of methamphetamine-induced motor abnormalities translate to an observable clinical phenotype?. Neuropsychopharmacology 2005; 30: 2125–2134
   PubMed Web of Science ®Google Scholar